Frontiers in Pharmacology | Drugs Outcomes Research and Policies

Original Research

Published on 12 Dec 2024

Association between anthropometric indices and hypertension: identifying optimal cutoff points for U.S. adults across different populations

in Drugs Outcomes Research and Policies

Xueliang Zhang
Yan Nie
Dan Li
Chunhua Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503059

1,379 views

Original Research

Published on 10 Dec 2024

Comparison of intravitreal anti-VEGF agents and oral carbonic anhydrase inhibitors in the treatment of cystoid macular edema secondary to retinitis pigmentosa

in Drugs Outcomes Research and Policies

Jia Liang
Xueping Wu
Lu Chen
Lujia Feng
Xiangqing Hei
Yingying Diao
Yuke Ji
Huiyan Zheng
Zhenhua Zou
Dong Fang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477889

994 views

Perspective

Published on 10 Dec 2024

Reframing risks in rare diseases: economics of networks, spillovers, and scale

in Drugs Outcomes Research and Policies

Carlisle Ford Runge
James Campbell
Carlisle P. Runge

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1516725

548 views

Original Research

Published on 06 Dec 2024

Despite the pandemic: upward trajectories of medication adherence and persistence in patients with dyslipidemia

in Drugs Outcomes Research and Policies

Jieun Jang
Hyun Jung Oh
Eui-Kyung Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488452

574 views

Systematic Review

Accepted on 04 Dec 2024

Ecopharmacovigilance future opportunities and challenges: A scoping review

in Drugs Outcomes Research and Policies

Michael Demian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1515318

123 views

Original Research

Published on 03 Dec 2024

Kidney outcomes associated with SGLT2 inhibitors compared to other glucose-lowering drugs: a real-world study from China

in Drugs Outcomes Research and Policies

Xiang Xiao
Shuming Ji
Tao Zheng
Tianzhu Wang
Dapeng Jiang
Fang Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1468435

1,013 views

Original Research

Published on 02 Dec 2024

Literature review of the clinical features of sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms/drug-induced hypersensitivity syndrome (DRESS/DIHS)

in Drugs Outcomes Research and Policies

Ya Liu
Danxia Wang
Shiwei Wu
Xiang Liu
Can Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488483

1,316 views

Review

Published on 02 Dec 2024

Medication adherence in allergic diseases and asthma: a literature review

in Drugs Outcomes Research and Policies

Elizabeth Malaya
Adrianna Piątkowska
Michał Panek
Piotr Kuna
Maciej Kupczyk
Grzegorz Kardas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488665

2,262 views

Original Research

Published on 29 Nov 2024

Effects of pharmacogenomics-guided treatment on medication adherence and the antidepressant switching rate in major depressive disorder

in Drugs Outcomes Research and Policies

Chaoli Chen
Yang Lun
Jing Yu
Xiaochuan Zhao
Shi Su
Mengqiang Zhao
Yuhang Yan
Jiaqi Wang
Ran Fu
Feiyue An

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1501381

1,012 views

Original Research

Published on 28 Nov 2024

Trajectories of adherence to intravenous biological treatment in patients with inflammatory bowel disease: a longitudinal analysis

in Drugs Outcomes Research and Policies

Xiuli Dong
Suyan Zhu
Yiyi Jin
Chaoqun Ren
Chunyan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1431035

870 views

Systematic Review

Published on 26 Nov 2024

Association between various types of corticosteroids and mortality for severe community-acquired pneumonia in adults: a systematic review and network meta-analysis

in Drugs Outcomes Research and Policies

Peng Wang
Jun Wan
Qiaoyu You
Yuxin Zheng
Wenhao Xu
Jialing He
Liyuan Peng
Cuyubamba Dominguez Jorge Luis
Yuning Feng
Ping Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1479804

1,468 views

Original Research

Published on 26 Nov 2024

Machine learning models for coagulation dysfunction risk in inpatients administered β-lactam antibiotics

in Drugs Outcomes Research and Policies

Yuqing Hua
Na Li
Jiahui Lao
Zhaoyang Chen
Shiyu Ma
Xiao Li

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503713

838 views

Editorial

Published on 25 Nov 2024

Editorial: Recent advances in attempts to improve medication adherence – from basic research to clinical practice, volume II

in Drugs Outcomes Research and Policies

Przemyslaw Kardas
Ines Potočnjak
Cristina Mihaela Ghiciuc
Maria Teresa Herdeiro
Tamas Agh

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1521468

1,420 views

Review

Published on 22 Nov 2024

Expert consensus on the off-label use in China of drugs for rare hematologic diseases (2024 edition)

in Drugs Outcomes Research and Policies

Boxin Zhao
Xuan Zhou
Ping Zheng
Bo Zhang
Xiaoqin Feng
Jie Chen
Lisheng Cai
Yilu Chen
Liya He
Jianfen Su

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1477550

1,225 views

Original Research

Published on 20 Nov 2024

Cost-effectiveness analysis of tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced gastric or gastroesophageal junction adenocarcinoma: perspectives from the United States and China

in Drugs Outcomes Research and Policies

Wenwang Lang
Qi Ai
Wenwen Zhang
Qinling Jiang
Yulong He
Ming Ouyang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1461571

1,346 views

Original Research

Published on 20 Nov 2024

A real-world pharmacovigilance analysis of adverse events associated with irbesartan using the FAERS and JADER databases

in Drugs Outcomes Research and Policies

Qian Liu
Zhiwei Cui
Chao Deng
Chao Yang
Tao Shi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1485190

3,332 views
2 citations